# Western New England Bancorp, Inc.: financial statements, quarterly

WNEB · Nasdaq · CIK 1157647 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/wneb.md) · [Financials](/companies/wneb/financials.md) · [Filings](/companies/wneb/filings.md) · [Insiders](/companies/wneb/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/wneb/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Interest expense | $m | [9.5](/filings/0001839882-25-014778.md) | [10.6](/filings/0001839882-25-014778.md) | [11.3](/filings/0001999371-26-006029.md) | [12.3](/filings/0001999371-26-006029.md) | [13.1](/filings/0001999371-26-006029.md) | [13.3](/filings/0001999371-26-006029.md) | [12.9](/filings/0001999371-26-006029.md) | [12.0](/filings/0001999371-26-006029.md) | [11.9](/filings/0001999371-26-006029.md) | [11.7](/filings/0001999371-26-006029.md) | not reported | not reported |
| Income tax | $m | [1.0](/filings/0001839882-25-014778.md) | [1.1](/filings/0001839882-25-014778.md) | [0.8](/filings/0001999371-26-006029.md) | [0.8](/filings/0001999371-26-006029.md) | [0.6](/filings/0001999371-26-006029.md) | [1.1](/filings/0001999371-26-006029.md) | [0.7](/filings/0001999371-26-010347.md) | [1.4](/filings/0001999371-26-017418.md) | [1.0](/filings/0001999371-26-006029.md) | [1.4](/filings/0001999371-26-006029.md) | [1.4](/filings/0001999371-26-010347.md) | [1.2](/filings/0001999371-26-017418.md) |
| Net income | $m | [4.5](/filings/0001839882-25-014778.md) | [2.5](/filings/0001839882-25-014778.md) | [3.0](/filings/0001999371-26-006029.md) | [3.5](/filings/0001999371-26-006029.md) | [1.9](/filings/0001999371-26-006029.md) | [3.3](/filings/0001999371-26-006029.md) | [2.3](/filings/0001999371-26-017418.md) | [4.6](/filings/0001999371-26-017418.md) | [3.2](/filings/0001999371-26-006029.md) | [5.2](/filings/0001999371-26-006029.md) | [4.8](/filings/0001999371-26-017418.md) | [3.6](/filings/0001999371-26-017418.md) |
| Diluted EPS | $ per share | [0.21](/filings/0001839882-25-014778.md) | [0.12](/filings/0001839882-25-014778.md) | [0.14](/filings/0001999371-26-006029.md) | [0.17](/filings/0001999371-26-006029.md) | [0.09](/filings/0001999371-26-006029.md) | [0.16](/filings/0001999371-26-006029.md) | [0.11](/filings/0001999371-26-010347.md) | [0.23](/filings/0001999371-26-017418.md) | [0.16](/filings/0001999371-26-006029.md) | [0.26](/filings/0001999371-26-006029.md) | [0.24](/filings/0001999371-26-010347.md) | [0.18](/filings/0001999371-26-017418.md) |
| Basic EPS | $ per share | [0.21](/filings/0001839882-25-014778.md) | [0.12](/filings/0001839882-25-014778.md) | [0.14](/filings/0001999371-26-006029.md) | [0.17](/filings/0001999371-26-006029.md) | [0.09](/filings/0001999371-26-006029.md) | [0.16](/filings/0001999371-26-006029.md) | [0.11](/filings/0001999371-26-010347.md) | [0.23](/filings/0001999371-26-017418.md) | [0.16](/filings/0001999371-26-006029.md) | [0.26](/filings/0001999371-26-006029.md) | [0.24](/filings/0001999371-26-010347.md) | [0.18](/filings/0001999371-26-017418.md) |

- Revenue: not reported
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Total assets | $m | [2,585](/filings/0001387131-23-013074.md) | [2,565](/filings/0001839882-25-014778.md) | [2,557](/filings/0001999371-24-005722.md) | [2,586](/filings/0001999371-24-009828.md) | [2,640](/filings/0001999371-24-014440.md) | [2,653](/filings/0001999371-26-006029.md) | [2,709](/filings/0001999371-25-005780.md) | [2,711](/filings/0001999371-25-010984.md) | [2,736](/filings/0001999371-25-017260.md) | [2,736](/filings/0001999371-26-017418.md) | [2,765](/filings/0001999371-26-010347.md) | [2,732](/filings/0001999371-26-017418.md) |
| Total liabilities | $m | [2,354](/filings/0001387131-23-013074.md) | [2,327](/filings/0001839882-25-014778.md) | [2,321](/filings/0001999371-24-005722.md) | [2,350](/filings/0001999371-24-009828.md) | [2,400](/filings/0001999371-24-014440.md) | [2,417](/filings/0001999371-26-006029.md) | [2,472](/filings/0001999371-25-005780.md) | [2,472](/filings/0001999371-25-010984.md) | [2,492](/filings/0001999371-25-017260.md) | [2,489](/filings/0001999371-26-017418.md) | [2,516](/filings/0001999371-26-010347.md) | [2,484](/filings/0001999371-26-017418.md) |
| Long-term debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Short-term borrowings | $m | [8.9](/filings/0001387131-23-013074.md) | [16.1](/filings/0001839882-25-014778.md) | [11.5](/filings/0001999371-24-005722.md) | [6.6](/filings/0001999371-24-009828.md) | [4.4](/filings/0001999371-24-014440.md) | [5.4](/filings/0001999371-26-006029.md) | [4.5](/filings/0001999371-25-005780.md) | [4.0](/filings/0001999371-25-010984.md) | [3.0](/filings/0001999371-25-017260.md) | [13.3](/filings/0001999371-26-017418.md) | [23.8](/filings/0001999371-26-010347.md) | [17.7](/filings/0001999371-26-017418.md) |
| Shareholders' equity | $m | [231](/filings/0001999371-24-014440.md) | [237](/filings/0001999371-26-006029.md) | [236](/filings/0001999371-25-017260.md) | [236](/filings/0001999371-25-017260.md) | [241](/filings/0001999371-25-017260.md) | [236](/filings/0001999371-26-017418.md) | [238](/filings/0001999371-26-017418.md) | [239](/filings/0001999371-26-017418.md) | [244](/filings/0001999371-25-017260.md) | [248](/filings/0001999371-26-017418.md) | [248](/filings/0001999371-26-017418.md) | [248](/filings/0001999371-26-017418.md) |

- Cash and equivalents: not reported
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Long-term debt: not reported
- Short-term borrowings: us-gaap:ShortTermBorrowings
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $k | [7,645 d](/filings/0001999371-24-014440.md) | [8,862 d](/filings/0001999371-26-006029.md) | [1,172](/filings/0001999371-25-005780.md) | [1,963 d](/filings/0001999371-25-010984.md) | [2,980 d](/filings/0001999371-25-017260.md) | [6,055 d](/filings/0001999371-26-006029.md) | [(829)](/filings/0001999371-26-010347.md) | [6,838 d](/filings/0001999371-26-017418.md) | [5,146 d](/filings/0001999371-25-017260.md) | [7,058 d](/filings/0001999371-26-006029.md) | [346](/filings/0001999371-26-010347.md) | [6,640 d](/filings/0001999371-26-017418.md) |
| Capital expenditure | $k | [712 d](/filings/0001999371-24-014440.md) | [1,393 d](/filings/0001999371-26-006029.md) | not reported | not reported | not reported | [815 d](/filings/0001999371-26-006029.md) | [287](/filings/0001999371-26-010347.md) | [295 d](/filings/0001999371-26-017418.md) | [(172) d](/filings/0001999371-25-017260.md) | [663 d](/filings/0001999371-26-006029.md) | [734](/filings/0001999371-26-010347.md) | [768 d](/filings/0001999371-26-017418.md) |
| Dividends paid | $k | [1,521 d](/filings/0001999371-24-014440.md) | [1,484 d](/filings/0001999371-26-006029.md) | [1,504](/filings/0001999371-25-005780.md) | [1,494 d](/filings/0001999371-25-010984.md) | [1,471 d](/filings/0001999371-25-017260.md) | [1,445 d](/filings/0001999371-26-006029.md) | [1,439](/filings/0001999371-26-010347.md) | [1,437 d](/filings/0001999371-26-017418.md) | [1,419 d](/filings/0001999371-25-017260.md) | [1,417 d](/filings/0001999371-26-006029.md) | [1,373](/filings/0001999371-26-010347.md) | [1,396 d](/filings/0001999371-26-017418.md) |
| Share repurchases | $k | [966 d](/filings/0001999371-24-014440.md) | [1,919 d](/filings/0001999371-26-006029.md) | [1,834](/filings/0001999371-25-005780.md) | [1,685 d](/filings/0001999371-25-010984.md) | [2,102 d](/filings/0001999371-25-017260.md) | [1,978 d](/filings/0001999371-26-006029.md) | [2,106](/filings/0001999371-26-010347.md) | [2,787 d](/filings/0001999371-26-017418.md) | [24.0 d](/filings/0001999371-25-017260.md) | [1,180 d](/filings/0001999371-26-006029.md) | [2,750](/filings/0001999371-26-010347.md) | [2,692 d](/filings/0001999371-26-017418.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividends
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [21.8](/filings/0001387131-23-013074.md) | [21.7](/filings/0001999371-24-005722.md) | [21.6](/filings/0001999371-24-009828.md) | [21.7](/filings/0001999371-24-014440.md) | [21.3](/filings/0001999371-25-005780.md) | [21.2](/filings/0001999371-25-010984.md) | [20.9](/filings/0001999371-25-017260.md) | [20.5](/filings/0001999371-26-010347.md) | [20.3](/filings/0001999371-26-017418.md) | [20.2](/filings/0001999371-25-017260.md) | [20.1](/filings/0001999371-26-010347.md) | [19.9](/filings/0001999371-26-017418.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 20,045,872 at 2026-08-03, from the cover of the [10-Q filed 2026-08-07](/filings/0001999371-26-017418.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:34 ET. No prices; not investment advice.